Communications & Publications 2020\u20132025<\/title>\n <style>\n :root{\n --bg:#f7f9fc; --card:#ffffff; --text:#0b1324; --muted:#6b7280;\n --primary:#0ea5e9; --primary-600:#0284c7; --border:#e5e7eb;\n --shadow:0 10px 30px rgba(2,8,23,.08); --radius:18px;\n --ring:0 0 0 6px rgba(14,165,233,.10);\n }\n body{background:var(--bg); color:var(--text); font-family:system-ui,Segoe UI,Roboto,Helvetica,Arial,sans-serif; line-height:1.65; margin:0}\n a{color:var(--primary-600); text-decoration:none}\n a:hover{text-decoration:underline}\n .container{max-width:1280px;margin:0 auto;padding:22px 20px 96px}\n .hero{background:radial-gradient(1000px 500px at 10% -10%,rgba(14,165,233,.10),transparent),radial-gradient(800px 400px at 90% 0%,rgba(142,68,173,.06),transparent);border:1px solid var(--border);border-radius:28px;padding:30px;box-shadow:var(--shadow)}\n .hero h1{margin:0 0 8px;font-size:2.15rem;letter-spacing:-.02em}\n .quicknav{display:flex;flex-wrap:wrap;gap:10px;margin:16px 0 0}\n .quicknav a{color:#0b1324; font-weight:700; padding:10px 16px; border-radius:999px;border:1px solid var(--border); background:#fff; box-shadow:0 6px 18px rgba(2,8,23,.06);transition:transform .15s ease, box-shadow .2s ease}\n .quicknav a:hover{transform:translateY(-2px); box-shadow:0 14px 28px rgba(2,8,23,.10)}\n section{margin-top:26px}\n .card{background:var(--card);border:1px solid var(--border);border-radius:24px;padding:24px 24px 18px;box-shadow:var(--shadow)}\n .section-header{display:flex;align-items:center;gap:12px;margin:0 0 10px}\n .section-header h2{margin:0;font-size:1.35rem}\n .pill{display:inline-flex;align-items:center;justify-content:center;width:40px;height:40px;border-radius:14px;background:linear-gradient(180deg,rgba(14,165,233,.20),rgba(14,165,233,.08));border:1px solid rgba(14,165,233,.25)}\n .pill svg{width:20px;height:20px;stroke:var(--primary-600)}\n h3.muted{color:#0b1324;margin:12px 0 4px;font-size:1rem; font-weight:800; text-transform:uppercase; letter-spacing:.08em}\n ol{margin:4px 0 0;padding-left:0}\n li{list-style:none;margin:12px 0;padding:12px 14px;border:1px dashed var(--border);border-radius:14px;background:#fafcff}\n li:hover{background:#fff; border-color:#d7ddea; box-shadow:0 8px 20px rgba(2,8,23,.06)}\n .muted{color:var(--muted)}\n\n .two-cols {\n display: grid;\n grid-template-columns: 2fr 1fr;\n gap: 24px;\n margin-top: 30px;\n }\n .col-left {display:flex;flex-direction:column;gap:22px}\n .col-right {position:sticky;top:20px;height:fit-content}\n @media (max-width: 900px) {\n .two-cols {grid-template-columns:1fr}\n .col-right {position:relative;top:auto}\n }\n\n .info-grid{display:flex;flex-direction:column;gap:14px}\n .info{\n padding:14px 16px;\n border:1px solid var(--border);\n border-radius:16px;\n background:#fafcff;\n box-shadow:0 6px 18px rgba(2,8,23,.04);\n }\n .info strong{display:inline-block;margin-bottom:4px}\n .info.featured{\n background:linear-gradient(135deg,rgba(14,165,233,.08),rgba(142,68,173,.06));\n border-color:#cfe7f5;\n }\n .badge{\n display:inline-block;\n margin-left:8px;\n padding:3px 8px;\n border-radius:999px;\n font-size:.75rem;\n font-weight:800;\n color:#fff;\n background:linear-gradient(135deg,#0ea5e9,#8e44ad);\n vertical-align:middle;\n }\n <\/style>\n<\/head>\n<body>\n <div class=\"container\">\n <header class=\"hero\">\n <h1>Communications & Publications<\/h1>\n <nav class=\"quicknav\" aria-label=\"Navigation rapide\">\n <a href=\"#y2025\">2025<\/a>\n <a href=\"#y2024\">2024<\/a>\n <a href=\"#y2023\">2023<\/a>\n <a href=\"#y2022\">2022<\/a>\n <a href=\"#y2021\">2021<\/a>\n <a href=\"#y2020\">2020<\/a>\n <a href=\"#newsletters\">Newsletters<\/a>\n <\/nav>\n <\/header>\n\n <div class=\"two-cols\">\n <div class=\"col-left\">\n\n \n <section id=\"y2025\" class=\"card\">\n <div class=\"section-header\">\n <span class=\"pill\">\n <svg viewBox=\"0 0 24 24\" fill=\"none\" stroke-width=\"2\"><path d=\"M3 6h18M3 12h18M3 18h18\"><\/path><\/svg>\n <\/span>\n <h2>2025<\/h2>\n <\/div>\n\n <h3 class=\"muted\">Communications<\/h3>\n <ol>\n <li>Qu\u00e9n\u00e9herv\u00e9 L, Chagnon P, Morvan M, Arnachellum R, Cholet F, Bouzeloc S, Badic B, Doucet L, Nousbaum JB (Brest). Faut-il moins se m\u00e9fier des cancers colorectaux T1 d\u00e9velopp\u00e9s sur polypes p\u00e9dicul\u00e9s ? Une \u00e9tude r\u00e9trospective de population sur 12 ans. JFHOD; 20\u201323 mars <strong>2025<\/strong>; Paris. Poster.<\/li>\n <li>Motreff M, Morvan M, Arnachellum R, Cholet F, Bouzeloc S, Badic B, Doucet L, Nousbaum JB, Qu\u00e9n\u00e9herv\u00e9 L (Brest). Impact de la pr\u00e9sentation en r\u00e9union de concertation pluridisciplinaire des tumeurs superficielles digestives r\u00e9s\u00e9qu\u00e9es par endoscopie : \u00e9tude r\u00e9trospective. JFHOD; 20\u201323 mars <strong>2025<\/strong>; Paris. Communication orale.<\/li>\n <\/ol>\n\n <h3 class=\"muted\">Publications<\/h3>\n <ol>\n <li>Jooste V, Nousbaum JB, Alves A, Woronoff AS, Launoy G, Molini\u00e9 F, Desandes E, Delafosse P, Tretarre B, Mercier E, Lepage C, Ghiringhelli F, Bouvier AM; French Network of Cancer Registries (FRANCIM). Epidemiological Classification Changes and Incidence of Early-Onset Colorectal Cancer. JAMA Netw Open. <strong>2025<\/strong> Nov 3;8(11):e2541732. doi: 10.1001\/jamanetworkopen.2025.41732. PMID: 41191353; PMCID: PMC12590295.<\/li>\n <li>Botta L, Capocaccia R, Bernasconi A, Rossi S, Galceran J, Dal Maso L, Lepage C, Molini\u00e9 F, Bouvier AM, Marcos-Gragera R, Vener C, Guevara M, Murray D, Ragusa R, Gatta G, Jooste V; EUROCARE-6 WG. The impact of cancer survivors’ extra risk of noncancer mortality on net survival estimation. Am J Epidemiol. <strong>2025<\/strong> Nov 4;194(11):3316-3324. doi: 10.1093\/aje\/kwaf148. PMID: 40826891; PMCID: PMC12634115.<\/li>\n <li>Chaigneau T, Dejardin O, Nguyen TTN, Bouvier AM, Gardy J, Molinie F, Nousbaum JB, Tron L, Dupont B, Alves A, Launoy G, Bouvier V, Ollivier-Hourmand I; FRANCIM Group. The socioeconomic environment and access to care affect the survival of patients with hepatocellular carcinoma and intrahepatic cholangiocarcinoma. BMC Cancer. <strong>2025<\/strong> Nov 21. doi: 10.1186\/s12885-025-15174-w. Epub ahead of print. PMID: 41272602.<\/li>\n <li>Le Rochais M, Morvan M, Bouzeloc S, Nousbaum JB, Guillard M, Le Noac’h P, Garaud S, Uguen A. A tertiary lymphoid structures-based pathological score predicts survival and recurrence in colorectal cancer patients. <i>Immunobiology<\/i>. <strong>2025<\/strong>;230(3):152911. doi:10.1016\/j.imbio.2025.152911. PMID:40398138.<\/li>\n <li>Goebel G, Jooste V, Molinie F, Grosclaude P, Woronoff AS, Alves A, Bouvier V, Nousbaum JB, Plouvier S, Bengrine-Lefevre L, Rabel T, Bouvier AM; FRANCIM Network. Surgical patterns of care of pancreatic cancer: a French population-based study. <i>Eur J Surg Oncol<\/i>. <strong>2025<\/strong>;51(8):108748. doi:10.1016\/j.ejso.2024.108748. PMID:39419745.<\/li>\n <\/ol>\n <\/section>\n\n \n <section id=\"y2024\" class=\"card\">\n <div class=\"section-header\"><span class=\"pill\"><svg viewBox=\"0 0 24 24\" fill=\"none\" stroke-width=\"2\"><path d=\"M3 6h18M3 12h18M3 18h18\"><\/path><\/svg><\/span><h2>2024<\/h2><\/div>\n <h3 class=\"muted\">Communications<\/h3>\n <ol>\n <li>Chaigneau T, Dejardin O, Nguyen TTN, Bouvier AM, Gardy J, Molini\u00e9 F, Nousbaum JB, Tron L, Alves A, Launoy G, Bouvier V, Ollivier-Hourmand I. Influence de l\u2019acc\u00e8s aux soins et de l\u2019environnement socio-\u00e9conomique sur la survie des patients atteints de carcinome h\u00e9patocellulaire et de cholangiocarcinome intra-h\u00e9patique. JFHOD; 14\u201317 mars <strong>2024<\/strong>; Paris. Communication orale.<\/li>\n <li>Debuc Y, Morvan M, Can\u00e9vet M, Brousse-Potocki J, Kermarrec T, Bouzeloc S, Robaszkiewicz M, Reboux N, Qu\u00e9n\u00e9herv\u00e9 L, Nousbaum JB. Analyse et survie des patients atteints d\u2019un cancer colorectal selon le motif d\u2019exclusion du d\u00e9pistage organis\u00e9 (2016\u20132019). JFHOD; 14\u201317 mars <strong>2024<\/strong>; Paris. Poster.<\/li>\n <li>Kermarrec M, Robaszkiewicz M, Morvan M, Bideau K, Edeline J, Brousse-Potocki J, Grasset D, Lambert S, Metges JP, Langlois A, Pourchasse C, Desgrippes R. Cons\u00e9quence de la Covid-19 sur la prise en charge des patients atteints de cancer colorectal en Bretagne. JFHOD; 14\u201317 mars <strong>2024<\/strong>; Paris. Poster.<\/li>\n <\/ol>\n <h3 class=\"muted\">Publications<\/h3>\n <ol>\n <li>Gardy J, Wilson S, Guizard AV, Bouvier V, Launay L, Alves A, Bara S, Bouvier AM, Coureau G, Cowppli-Bony A, Dabakuyo Yonli S, Daubisse-Marliac L, Defossez G, Hammas K, Hure F, Jooste V, Lapotre-Ledoux B, Nousbaum JB, Plouvier S, Seigneurin A, Tretarre B, Vigneron N, Woronoff AS, Launoy G, Molinie F, Bryere J, Dejardin O. Access to primary care and mortality in excess for patients with cancer in France: results from 21 registries. <i>Cancer<\/i>. <strong>2024<\/strong>;130(23):4096\u20134108. doi:10.1002\/cncr.35519. PMID:39163260.<\/li>\n <li>Comoz B, Ollivier-Hourmand I, Bouvier AM, Nousbaum JB, Nguyen TTN, Launoy G, Bouvier V, Bryere J. Impact of socio-economic environment on incidence of primary liver cancer in France between 2006 and 2016. <i>Liver Int<\/i>. <strong>2024<\/strong>;44(2):446\u2013453. doi:10.1111\/liv.15784. PMID:38010978.<\/li>\n <li>Toudic HP, Morvan M, Reboux N, Chaussade S, Gronier O, Koch S, Bernardini D, Coron E, Robaszkiewicz M, Qu\u00e9n\u00e9herv\u00e9 L. Expansion of interventional endoscopy and day-case procedures: a nationwide longitudinal study of gastrointestinal endoscopy in France. <i>Clin Res Hepatol Gastroenterol<\/i>. <strong>2024<\/strong>;49(1):102505. doi:10.1016\/j.clinre.2024.102505. PMID:39608706.<\/li>\n <li>Sant M, Vener C, Lillini R, Rossi S, Bonfarnuzzo S, Marcos-Gragera R, Maynadi\u00e9 M, Innos K, Paapsi K, Visser O, Bernasconi A, Demuru E, Di Benedetto C, Mousavi SM, Blum M, Went P, Serraino D, Bennett D, S\u00e1nchez MJ, De Angelis R; EUROCARE-6 Working Group. Long-term survival for lymphoid neoplasms and national health expenditure (EUROCARE-6). <i>Lancet Oncol<\/i>. <strong>2024<\/strong>;25(6):731\u2013743. doi:10.1016\/S1470-2045(24)00141-4. PMID:38703784.<\/li>\n <li>Botta L, Capocaccia R, Bernasconi A, Rossi S, Galceran J, Maso DL, Lepage C, Molini\u00e9 F, Bouvier AM, Marcos-Gragera R, Vener C, Guevara M, Murray D, Ragusa R, Gatta G, Jooste V; EUROCARE-6 Working Group. Estimating cure and risk of death from other causes: EUROCARE-6 data. <i>Eur J Cancer<\/i>. <strong>2024<\/strong>;208:114187. doi:10.1016\/j.ejca.2024.114187. PMID:39013266.<\/li>\n <li>Bouvier AM, Jooste V, Lillini R, Marcos-Gragera R, Katalinic A, Giorgi Rossi P, Launoy G, Bouvier V, Guevara M, Ardanaz E, Rapiti Aylward E, Innos K, Barranco MR, Sant M; European High Resolution Working Group on Colorectum. Differences in survival and recurrence of colorectal cancer by stage across European registries. <i>Int J Cancer<\/i>. <strong>2024<\/strong>;155(5):807\u2013815. doi:10.1002\/ijc.34944. PMID:38577898.<\/li>\n <li>Jooste V, Grosclaude P, Defossez G, Daubisse L, Woronoff AS, Bouvier V, Chirpaz E, Tretarre B, Lapotre B, Plouvier S, Launoy G, Bonneault M, Molini\u00e9 F, Bouvier AM; FRANCIM Network. Net survival in colon and rectal cancer by stage according to neoadjuvant treatment: a French population-based study. <i>Dig Liver Dis<\/i>. <strong>2024<\/strong>;56(6):1064\u20131070. doi:10.1016\/j.dld.2023.10.012. PMID:37926634.<\/li>\n <\/ol>\n <\/section>\n\n \n <section id=\"y2023\" class=\"card\">\n <div class=\"section-header\"><span class=\"pill\"><svg viewBox=\"0 0 24 24\" fill=\"none\" stroke-width=\"2\"><path d=\"M3 6h18M3 12h18M3 18h18\"><\/path><\/svg><\/span><h2>2023<\/h2><\/div>\n <h3 class=\"muted\">Communications<\/h3>\n <ol>\n <li>Comoz B, Bryere J, Bouvier AM, Nousbaum JB, Launoy G, Bouvier V, Ollivier-Hourmand I. Disparit\u00e9s socio-\u00e9conomiques et incidence du cancer primitif du foie (2006\u20132016). JFHOD; 16\u201319 mars <strong>2023<\/strong>; Paris. Communication orale.<\/li>\n <li>Nguyen TTN, Dejardin O, Bouvier AM, Nousbaum JB, Molini\u00e9 F, Gardy J, Launoy G, Bouvier V, Ollivier-Hourmand I. In\u00e9galit\u00e9s socio-\u00e9conomiques et survie des cancers primitifs du foie. JFHOD; 16\u201319 mars <strong>2023<\/strong>; Paris. Communication orale.<\/li>\n <li>Corbel T, Morvan M, Bouzeloc S, Kermarrec T, Nousbaum JB, Le Reste JY, Reboux N, Qu\u00e9n\u00e9herv\u00e9 L, Robaszkiewicz M. Distribution des kits par pharmaciens et performance du d\u00e9pistage organis\u00e9 du cancer colorectal : \u00e9tude de population. JFHOD; 16\u201319 mars <strong>2023<\/strong>; Paris. Poster.<\/li>\n <\/ol>\n <h3 class=\"muted\">Publications<\/h3>\n <ol>\n <li>Badic B, Morvan M, Qu\u00e9n\u00e9herv\u00e9 L, Bouzeloc S, Kermarrec T, Nousbaum JB, Reboux N. Real world data for pancreatic adenocarcinoma from a population-based study in France. <i>Cancers (Basel)<\/i>. <strong>2023<\/strong>;15(2):525. doi:10.3390\/cancers15020525. PMID:36672474.<\/li>\n <li>Thobie A, Bouvier AM, Bouvier V, Jooste V, Quen\u00e9herv\u00e9 L, Nousbaum JB, Alves A, Dejardin O. Survival variability across hospitals after resection for pancreatic adenocarcinoma: a multilevel survival analysis. <i>Eur J Surg Oncol<\/i>. <strong>2023<\/strong>;49(8):1450\u20131456. doi:10.1016\/j.ejso.2023.03.228. PMID:37055280.<\/li>\n <li>Can\u00e9vet M, Pruvost-Couvreur M, Morvan M, Badic B, Brousse-Potocki J, Kermarrec T, Bouzeloc S, Nousbaum JB, Robaszkiewicz M, Reboux N, Qu\u00e9n\u00e9herv\u00e9 L. Sensitivity of fecal immunochemical test and risk factors for interval colorectal cancer in a French population. <i>Clin Res Hepatol Gastroenterol<\/i>. <strong>2023<\/strong>;47(3):102093. doi:10.1016\/j.clinre.2023.102093. PMID:36764389.<\/li>\n <li>Matz M, Valkov M, \u0160ekerija M, Luttman S, Caldarella A, Coleman MP, Allemani C; CONCORD Working Group. Worldwide trends in esophageal cancer survival, by sub-site, morphology, and sex: an analysis of 696,974 adults diagnosed in 60 countries during 2000\u20132014(CONCORD-3). <i>Cancer Commun (Lond)<\/i>. <strong>2023<\/strong>;43(9):963\u2013980. doi:10.1002\/cac2.12457. PMID:37488785.<\/li>\n <li>Nik\u0161i\u0107 M, Minicozzi P, Weir HK, Zimmerman H, Schymura MJ, Rees JR, Coleman MP, Allemani C; US CONCORD Working Group. Pancreatic cancer survival trends in the US from 2001 to 2014: a CONCORD-3 study. <i>Cancer Commun (Lond)<\/i>. <strong>2023<\/strong>;43(1):87\u201399. doi:10.1002\/cac2.12375. PMID:36353792.<\/li>\n <li>Tron L, Remontet L, Fauvernier M, Rachet B, Belot A, Launay L, Merville O, Molini\u00e9 F, Dejardin O, Francim Group, Launoy G. Is the social gradient in net survival observed in France the result of inequalities in cancer-specific mortality or inequalities in general mortality? <i>Cancers (Basel)<\/i>. <strong>2023<\/strong>;15(3):659. doi:10.3390\/cancers15030659. PMID:36765616.<\/li>\n <li>Demuru E, Rossi S, Ventura L, Dal Maso L, Guzzinati S, Katalinic A, Lamy S, Jooste V, Di Benedetto C, De Angelis R; EUROCARE-6 Working Group. Estimating complete cancer prevalence in Europe: validity of alternative vs standard completeness indexes. <i>Front Oncol<\/i>. <strong>2023<\/strong>;13:1114701. doi:10.3389\/fonc.2023.1114701. PMID:37168378.<\/li>\n <\/ol>\n <\/section>\n\n \n <section id=\"y2022\" class=\"card\">\n <div class=\"section-header\"><span class=\"pill\"><svg viewBox=\"0 0 24 24\" fill=\"none\" stroke-width=\"2\"><path d=\"M3 6h18M3 12h18M3 18h18\"><\/path><\/svg><\/span><h2>2022<\/h2><\/div>\n <h3 class=\"muted\">Communications<\/h3>\n <ol>\n <li>Canevet M, Pruvost-Couvreur M, Badic B, Brousse-Potocki J, Le Reun S, Kermarrec T, Bouzeloc S, Nousbaum JB, Robaszkiewicz M, Reboux N, Qu\u00e9n\u00e9herv\u00e9 L. Sensitivity of faecal immunochemical test for colorectal cancer screening and risk factors for interval cancer: a French population-based study. ESGE Days <strong>2022<\/strong>; Prague. Communication orale.<\/li>\n <li>Gieu M, Pruvost-Couvreur M, Kermarrec T, Bouzeloc S, Reboux N, Poureau PG, Metges JP, Robaszkiewicz M, Nousbaum JB, Qu\u00e9n\u00e9herv\u00e9 L. Facteurs associ\u00e9s \u00e0 la non-pr\u00e9sentation en RCP des patients atteints d\u2019un cancer de l\u2019\u0153sophage, de la JOG et de l\u2019estomac. JFHOD <strong>2022<\/strong>; Paris. Poster.<\/li>\n <li>Canevet M, Pruvost-Couvreur M, Kermarrec T, Bouzeloc S, Brousse-Potocki J, Le Reun S, Badic B, Nousbaum JB, Robaszkiewicz M, Reboux N, Qu\u00e9n\u00e9herv\u00e9 L. Sensibilit\u00e9 du test immunologique f\u00e9cal pour le d\u00e9pistage du CCR et risque de cancer d\u2019intervalle. JFHOD <strong>2022<\/strong>; Paris. Poster.<\/li>\n <\/ol>\n <h3 class=\"muted\">Publications<\/h3>\n <ol>\n <li>Reboux N, Jooste V, Goungounga J, Robaszkiewicz M, Nousbaum JB, Bouvier AM. Incidence and survival in synchronous and metachronous liver metastases from colorectal cancer. <i>JAMA Netw Open<\/i>. <strong>2022<\/strong>;5(10):e2236666.<\/li>\n <li>Badic B, Bouvier AM, Bouvier V, Morvan M, Jooste V, Alves A, Nousbaum JB, Reboux N. Predictors of survival in elderly patients with metastatic colon cancer: a population-based cohort study. <i>Cancers (Basel)<\/i>. <strong>2022<\/strong>;14(21):5208.<\/li>\n <li>Mulliri A, Gardy J, Cariou M, Launoy G, Robaszkiewicz M, Alves A, Bouvier V, Dejardin O. Care management and survival of patients diagnosed with synchronous metastatic colorectal cancer: a population-based study. <i>Cancers (Basel)<\/i>. <strong>2022<\/strong>;14(7):1777.<\/li>\n <li>Thomas F, Bouvier AM, Cariou M, Bouvier V, Jooste V, Pouchucq C, Gardy J, Qu\u00e9n\u00e9herv\u00e9 L, Launoy G, Alves A, Eid Y, Dejardin O. Influence of non-clinical factors on restorative rectal cancer surgery. <i>Dig Liver Dis<\/i>. <strong>2022<\/strong>;54(2):258\u2013267.<\/li>\n <li>Reboux N, Cadieu E, Pruvost-Couvreur M, Cariou M, Kermarrec M, Kermarrec T, Bouzeloc S, Nousbaum JB, Robaszkiewicz M, Qu\u00e9n\u00e9herv\u00e9 L. Factors associated with non-presentation in a multidisciplinary team meeting for colon cancer. <i>Clin Res Hepatol Gastroenterol<\/i>. <strong>2022<\/strong>;46(8):101950.<\/li>\n <li>Aujoulat P, Le Goff D, Dany A, Robaszkiewicz M, Nousbaum JB, Derriennic J, Cariou M, Guillou M, Le Reste JY. Improvement of participation rate in CRC screening by training GPs in motivational interviewing (AmDepCCR). <i>Trials<\/i>. <strong>2022<\/strong>;23(1):144.<\/li>\n <li>Cardoso R, Guo F, Heisser T, De Schutter H, Van Damme N, Nilbert MC, Christensen J, et al. Overall and stage-specific survival of patients with screen-detected colorectal cancer in Europe. <i>Lancet Reg Health Eur<\/i>. <strong>2022<\/strong>;21:100458.<\/li>\n <li>Ssenyonga N, Stiller C, Nakata K, Shalkow J, Redmond S, Bulliard JL, et al; CONCORD Working Group. Worldwide trends in survival for leukaemia in children, adolescents, and young adults. <i>Lancet Child Adolesc Health<\/i>. <strong>2022<\/strong>;6(6):409\u2013431.<\/li>\n <\/ol>\n <\/section>\n\n \n <section id=\"y2021\" class=\"card\">\n <div class=\"section-header\"><span class=\"pill\"><svg viewBox=\"0 0 24 24\" fill=\"none\" stroke-width=\"2\"><path d=\"M3 6h18M3 12h18M3 18h18\"><\/path><\/svg><\/span><h2>2021<\/h2><\/div>\n <h3 class=\"muted\">Communications<\/h3>\n <ol>\n <li>Pruvost-Couvreur M, Kermarrec M (OncoBretagne). \u00c9tude de l\u2019exhaustivit\u00e9 de la pr\u00e9sentation en RCP pour le cancer du c\u00f4lon : \u00e9tude collaborative. Congr\u00e8s National des R\u00e9seaux de Canc\u00e9rologie; sept. <strong>2021<\/strong>. Communication orale.<\/li>\n <li>Garcia GA, Cariou M, Reboux N, Kermarrec T, Bouzeloc S, Robaszkiewicz M, Qu\u00e9n\u00e9herv\u00e9 L, Nousbaum JB. Survie des patients atteints de cholangiocarcinome intra-h\u00e9patique (2005\u20132017). JFHOD; 18\u201321 mars <strong>2021<\/strong>; Paris. Communication orale.<\/li>\n <li>Bouvier AM, Uhry Z, Bouvier V, Cariou M, Robaszkiewicz M, Remontet L, Coureau G, Tretarre B. Long term colorectal cancer survival in France : population-based study. 45e GRELL; 12\u201314 mai <strong>2021<\/strong>; Luxembourg. Communication orale.<\/li>\n <li>Gaye E, Cariou M, Bore P, Poureau PG, Bouzeloc S, Doucet L, Jestin-Letallec V, Bideau K, Thereaux J, Robaszkiewicz M, Metges JP. Survie des carcinomes \u00e9pidermo\u00efdes de l\u2019\u0153sophage et de la JOG m\u00e9tastatiques (2009\u20132018) \u2013 ESPErE. JFHOD; mars <strong>2021<\/strong>. Poster.<\/li>\n <li>Bore P, Cariou M, Gaye E, Bouzeloc S, Nousbaum JB, Robaszkiewicz M, Jestin-Letallec V, Bideau K, Thereaux J, Poureau PG, Metges JP. HEROIC \u2013 Attitudes th\u00e9rapeutiques et tol\u00e9rance des ad\u00e9nocarcinomes \u0153sogastriques HER2+. JFHOD; mars <strong>2021<\/strong>. Poster.<\/li>\n <li>Thomas Q, Cariou M, Qu\u00e9n\u00e9herv\u00e9 L, Kermarrec T, Kermarrec M, Bouzeloc S, Robaszkiewicz M, Nousbaum JB, Reboux N. Exhaustivit\u00e9 de la pr\u00e9sentation en RCP des carcinomes h\u00e9patocellulaires (2014\u20132016). JFHOD; mars <strong>2021<\/strong>. Poster.<\/li>\n <li>Cadieu E, Cariou M, Kermarrec M, Bouzeloc S, Reboux N, Nousbaum JB, Robaszkiewicz M, Qu\u00e9n\u00e9herv\u00e9 L. Exhaustivit\u00e9 de la pr\u00e9sentation en RCP des cancers du c\u00f4lon (2014\u20132016). JFHOD; mars <strong>2021<\/strong>. Poster.<\/li>\n <\/ol>\n <h3 class=\"muted\">Publications<\/h3>\n <ol>\n <li>Badic B, Oguer M, Cariou M, Kermarrec T, Bouzeloc S, Nousbaum JB, Robaszkiewicz M, Qu\u00e9n\u00e9herv\u00e9 L. Ostomy prevalence and survival in elderly patients with stage III and IV rectal cancer. <i>Geriatr Gerontol Int<\/i>. <strong>2021<\/strong>;21(8):670\u2013675.<\/li>\n <li>Badic B, Oguer M, Cariou M, Kermarrec T, Bouzeloc S, Nousbaum JB, Robaszkiewicz M, Qu\u00e9n\u00e9herv\u00e9 L. Prognostic factors for stage III colon cancer in patients \u226580 years. <i>Int J Colorectal Dis<\/i>. <strong>2021<\/strong>;36(4):811\u2013819.<\/li>\n <li>Castillon M, Kammerer-Jacquet SF, Cariou M, Costa S, Conq G, Samaison L, Douet-Guilbert N, Marcorelles P, Doucet L, Uguen A. FISH must be preferred to pan-TRK IHC for NTRK3-rearranged GIST. <i>Appl Immunohistochem Mol Morphol<\/i>. <strong>2021<\/strong>;29(8):626\u2013634.<\/li>\n <li>Bocciarelli C, Caumont C, Samaison L, Cariou M, Aline-Fardin A, Doucet L, Roudi\u00e9 J, Terris B, Merlio JP, Marcorelles P, Cappellen D, Uguen A. MSI-high RAS-BRAF wt colorectal adenocarcinomas with MLH1 loss harbor frequent targetable fusions. <i>Hum Pathol<\/i>. <strong>2021<\/strong>;114:99\u2013109.<\/li>\n <li>Cardoso R, Guo F, Heisser T, Hackl M, et al. CRC incidence, mortality, and stage distribution in Europe in the screening era. <i>Lancet Oncol<\/i>. <strong>2021<\/strong>;22(7):1002\u20131013.<\/li>\n <li>Defossez G, Uhry Z, Delafosse P, Dantony E, et al; FRANCIM. Cancer incidence and mortality trends in France (1990\u20132018). <i>BMC Cancer<\/i>. <strong>2021<\/strong>;21:726.<\/li>\n <li>Bouvier AM, Jooste V, Sanchez-Perez MJ, et al; Working Group on Colorectum. Management and survival of metastatic colorectal cancer in Europe. <i>Dig Liver Dis<\/i>. <strong>2021<\/strong>;53(5):639\u2013645.<\/li>\n <li>Girardi F, Rous B, Stiller CA, et al; CONCORD Working Group. Histology of brain tumors (2000\u20132014): a global population-based study. <i>Neuro Oncol<\/i>. <strong>2021<\/strong>;23(10):1765\u20131776.<\/li>\n <li>Tron L, Fauvernier M, Bouvier AM, Robaszkiewicz M, Bouvier V, Cariou M, Jooste V, Dejardin O, Remontet L, Alves A, FRANCIM Group, Molini\u00e9 F, Launoy G. Socioeconomic environment and survival in digestive cancers. <i>Cancers (Basel)<\/i>. <strong>2021<\/strong>;13(20):5156.<\/li>\n <li>Bouvier V, Cariou M, Bouvier AM, Nousbaum JB, Lecoffre C, de Brauer C, et al. Survie des personnes atteintes de cancer en France m\u00e9tropolitaine 1989\u20132018 \u2014 V\u00e9sicule et voies biliaires. INCa; <strong>2021<\/strong>.<\/li>\n <\/ol>\n <\/section>\n\n \n <section id=\"y2020\" class=\"card\">\n <div class=\"section-header\"><span class=\"pill\"><svg viewBox=\"0 0 24 24\" fill=\"none\" stroke-width=\"2\"><path d=\"M3 6h18M3 12h18M3 18h18\"><\/path><\/svg><\/span><h2>2020<\/h2><\/div>\n <h3 class=\"muted\">Communications<\/h3>\n <ol>\n <li>Drouet d’Aubigny A, Cariou M, Cholet F, Jezequel J, Arnachellum R, Risson JR, H\u00e9bert T, Nonent M, Robaszkiewicz M, Nousbaum JB. \u00c9laboration d’un score pronostique chez les malades ayant un obstacle biliaire n\u00e9oplasique. JFHOD; 26\u201329 mars <strong>2020<\/strong>; Paris. Communication orale.<\/li>\n <li>Cardoso R, Hackl M, Ihle P, De Schutter H, Van Damme N, Valerianova Z, et al. Trends in colorectal cancer incidence and stage distribution in Europe in the screening era. UEG Week; 10\u201314 oct. <strong>2020<\/strong>; Amsterdam. Communication orale.<\/li>\n <li>d’Aubigny A, Cariou M, Cholet F, Jezequel J, Arnachellum R, Risson JR, H\u00e9bert T, Nonent M, Robaszkiewicz M, Nousbaum JB. Elaboration of a prognostic score in patients with malignant biliary obstruction. ESGE Days; 23\u201325 avr. 2020; virtuel. Poster. <i>Endoscopy<\/i>. <strong>2020<\/strong>;52(S01):204. doi:10.1055\/s-0040-1704635.<\/li>\n <\/ol>\n <h3 class=\"muted\">Publications<\/h3>\n <ol>\n <li>Uhry Z, Chatignoux E, Dantony E, Colonna M, Roche L, Fauvernier M, Defossez G, Le Guyader-Peyrou S, Monnereau A, Grosclaude P, Bossard N, Remontet L; FRANCIM. Multidimensional penalized splines for incidence and mortality-trend analyses and validation of national cancer-incidence estimates. <i>Int J Epidemiol<\/i>. <strong>2020<\/strong>;49(6):1762\u20131770.<\/li>\n <li>Bouvier AM, Robaszkiewicz M, Jooste V, Cariou M, Drouillard A, Bouvier V, Nousbaum JB; FRANCIM. Trends in incidence of small bowel cancer according to histology: a population-based study. <i>J Gastroenterol<\/i>. <strong>2020<\/strong>;55(2):181\u2013188.<\/li>\n <li>Bourhis A, De Luca C, Cariou M, Vigliar E, Barel F, Conticelli F, Marcorelles P, Nousbaum JB, Robaszkiewicz M, Samaison L, Badic B, Doucet L, Troncone G, Uguen A. Evaluation of KRAS, NRAS and BRAF mutational status and microsatellite instability in early colorectal carcinomas invading the submucosa (pT1): towards an in-house molecular prognostication for pathologists? <i>J Clin Pathol<\/i>. <strong>2020<\/strong>;73(11):741\u2013747.<\/li>\n <li>Cariou M, El Fettouhi A, Kermarrec T, Bommelaere F, Foll Y, Nousbaum JB, Robaszkiewicz M, Qu\u00e9n\u00e9herv\u00e9 L. Comparative evaluation of two colorectal cancer screening campaigns using different faecal occult blood tests in a French area. <i>Cancer Epidemiol<\/i>. <strong>2020<\/strong>;69:101839.<\/li>\n <li>\u00ab Survie des personnes atteintes de cancer en France m\u00e9tropolitaine (1989\u20132018) \u00bb \u2014 sites digestifs (\u0153sophage \u2014 ad\u00e9nocarcinomes, \u0153sophage \u2014 \u00e9pidermo\u00efdes et synth\u00e8se, estomac, c\u00f4lon, rectum, c\u00f4lon & rectum, anus, foie, pancr\u00e9as). Boulogne-Billancourt : INCa; <strong>2020<\/strong>.<\/li>\n <\/ol>\n <\/section>\n\n <\/div>\n\n \n <div class=\"col-right\">\n <section id=\"newsletters\" class=\"card\">\n <div class=\"section-header\">\n <span class=\"pill\">\n <svg viewBox=\"0 0 24 24\" fill=\"none\" stroke-width=\"2\">\n <path d=\"M4 4h16v16H4z\"><\/path>\n <path d=\"M4 9h16\"><\/path>\n <path d=\"M9 15h1\"><\/path>\n <\/svg>\n <\/span>\n <h2>Newsletters du Registre<\/h2>\n <\/div>\n\n <div class=\"info-grid\">\n <div class=\"info featured\">\n <strong>Newsletter RTDF 2026<\/strong>\n <span class=\"badge\">Nouveau<\/span><br \/>\n <a href=\"https:\/\/registre-tumeurs-29.fr\/wp-content\/uploads\/2026\/03\/2026_Newsletter_Registre_Finistere.pdf\" target=\"_blank\" rel=\"noopener\">T\u00e9l\u00e9charger (PDF)<\/a>\n <\/div>\n\n <div class=\"info\">\n <strong>Newsletter RTDF 2025<\/strong><br \/>\n <a href=\"https:\/\/registre-tumeurs-29.fr\/wp-content\/uploads\/2025\/09\/Newsletter_RTDF_2025.pdf\" target=\"_blank\" rel=\"noopener\">T\u00e9l\u00e9charger (PDF)<\/a>\n <\/div>\n\n <div class=\"info\">\n <strong>Newsletter RTDF 2024<\/strong><br \/>\n <a href=\"https:\/\/registre-tumeurs-29.fr\/wp-content\/uploads\/2024\/06\/Newsletter-Registre-du-Finistere_2024.pdf\" target=\"_blank\" rel=\"noopener\">T\u00e9l\u00e9charger (PDF)<\/a>\n <\/div>\n\n <div class=\"info\">\n <strong>Lettre d\u2019information RTDF 2021<\/strong><br \/>\n <a href=\"https:\/\/registre-tumeurs-29.fr\/wp-content\/uploads\/2021\/11\/Lettre-information-RTDF-2021.pdf\" target=\"_blank\" rel=\"noopener\">T\u00e9l\u00e9charger (PDF)<\/a>\n <\/div>\n <\/div>\n <\/section>\n <\/div>\n\n <\/div>\n <\/div>\n<\/body>\n<\/html>\n\n\n\n\n<p><\/p>","protected":false},"excerpt":{"rendered":"<p>Communications & Publications 2020\u20132025 Communications & Publications 2025 2024 2023 2022 2021 2020 Newsletters 2025 Communications Qu\u00e9n\u00e9herv\u00e9 L, Chagnon P, Morvan M, Arnachellum R, Cholet F, Bouzeloc S, Badic B, Doucet L, Nousbaum JB (Brest). Faut-il moins se m\u00e9fier des cancers colorectaux T1 d\u00e9velopp\u00e9s sur polypes p\u00e9dicul\u00e9s ? Une \u00e9tude r\u00e9trospective de population sur 12 […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":15,"comment_status":"closed","ping_status":"closed","template":"","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":[],"rop_publish_now_history":[],"rop_publish_now_status":"pending","_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":""},"class_list":["post-1315","page","type-page","status-publish","hentry"],"yoast_head":"\n<title>Publications et communications - REGISTRE DES TUMEURS DIGESTIVES DU FINISTERE<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/registre-tumeurs-29.fr\/Accueil\/travaux-et-resultats\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Publications et communications - REGISTRE DES TUMEURS DIGESTIVES DU FINISTERE\" \/>\n<meta property=\"og:description\" content=\"Communications & Publications 2020\u20132025 Communications & Publications 2025 2024 2023 2022 2021 2020 Newsletters 2025 Communications Qu\u00e9n\u00e9herv\u00e9 L, Chagnon P, Morvan M, Arnachellum R, Cholet F, Bouzeloc S, Badic B, Doucet L, Nousbaum JB (Brest). Faut-il moins se m\u00e9fier des cancers colorectaux T1 d\u00e9velopp\u00e9s sur polypes p\u00e9dicul\u00e9s ? Une \u00e9tude r\u00e9trospective de population sur 12 […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/registre-tumeurs-29.fr\/Accueil\/travaux-et-resultats\/\" \/>\n<meta property=\"og:site_name\" content=\"REGISTRE DES TUMEURS DIGESTIVES DU FINISTERE\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-12T13:45:42+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"14 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/registre-tumeurs-29.fr\/Accueil\/travaux-et-resultats\/\",\"url\":\"https:\/\/registre-tumeurs-29.fr\/Accueil\/travaux-et-resultats\/\",\"name\":\"Publications et communications - REGISTRE DES TUMEURS DIGESTIVES DU FINISTERE\",\"isPartOf\":{\"@id\":\"https:\/\/registre-tumeurs-29.fr\/Accueil\/#website\"},\"datePublished\":\"2019-02-20T15:48:35+00:00\",\"dateModified\":\"2026-03-12T13:45:42+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/registre-tumeurs-29.fr\/Accueil\/travaux-et-resultats\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/registre-tumeurs-29.fr\/Accueil\/travaux-et-resultats\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/registre-tumeurs-29.fr\/Accueil\/travaux-et-resultats\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/registre-tumeurs-29.fr\/Accueil\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Publications et communications\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/registre-tumeurs-29.fr\/Accueil\/#website\",\"url\":\"https:\/\/registre-tumeurs-29.fr\/Accueil\/\",\"name\":\"REGISTRE DES TUMEURS DIGESTIVES DU FINISTERE\",\"description\":\"Equipe d'Accueil EA 7479 SPURBO - Soins Primaires, Sant\u00e9 Publique et Registre des cancers de Bretagne Occidentale\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/registre-tumeurs-29.fr\/Accueil\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"}]}<\/script>\n","yoast_head_json":{"title":"Publications et communications - REGISTRE DES TUMEURS DIGESTIVES DU FINISTERE","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/registre-tumeurs-29.fr\/Accueil\/travaux-et-resultats\/","og_locale":"fr_FR","og_type":"article","og_title":"Publications et communications - REGISTRE DES TUMEURS DIGESTIVES DU FINISTERE","og_description":"Communications & Publications 2020\u20132025 Communications & Publications 2025 2024 2023 2022 2021 2020 Newsletters 2025 Communications Qu\u00e9n\u00e9herv\u00e9 L, Chagnon P, Morvan M, Arnachellum R, Cholet F, Bouzeloc S, Badic B, Doucet L, Nousbaum JB (Brest). Faut-il moins se m\u00e9fier des cancers colorectaux T1 d\u00e9velopp\u00e9s sur polypes p\u00e9dicul\u00e9s ? Une \u00e9tude r\u00e9trospective de population sur 12 […]","og_url":"https:\/\/registre-tumeurs-29.fr\/Accueil\/travaux-et-resultats\/","og_site_name":"REGISTRE DES TUMEURS DIGESTIVES DU FINISTERE","article_modified_time":"2026-03-12T13:45:42+00:00","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"14 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/registre-tumeurs-29.fr\/Accueil\/travaux-et-resultats\/","url":"https:\/\/registre-tumeurs-29.fr\/Accueil\/travaux-et-resultats\/","name":"Publications et communications - REGISTRE DES TUMEURS DIGESTIVES DU FINISTERE","isPartOf":{"@id":"https:\/\/registre-tumeurs-29.fr\/Accueil\/#website"},"datePublished":"2019-02-20T15:48:35+00:00","dateModified":"2026-03-12T13:45:42+00:00","breadcrumb":{"@id":"https:\/\/registre-tumeurs-29.fr\/Accueil\/travaux-et-resultats\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/registre-tumeurs-29.fr\/Accueil\/travaux-et-resultats\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/registre-tumeurs-29.fr\/Accueil\/travaux-et-resultats\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/registre-tumeurs-29.fr\/Accueil\/"},{"@type":"ListItem","position":2,"name":"Publications et communications"}]},{"@type":"WebSite","@id":"https:\/\/registre-tumeurs-29.fr\/Accueil\/#website","url":"https:\/\/registre-tumeurs-29.fr\/Accueil\/","name":"REGISTRE DES TUMEURS DIGESTIVES DU FINISTERE","description":"Equipe d'Accueil EA 7479 SPURBO - Soins Primaires, Sant\u00e9 Publique et Registre des cancers de Bretagne Occidentale","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/registre-tumeurs-29.fr\/Accueil\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"}]}},"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/registre-tumeurs-29.fr\/Accueil\/wp-json\/wp\/v2\/pages\/1315","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/registre-tumeurs-29.fr\/Accueil\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/registre-tumeurs-29.fr\/Accueil\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/registre-tumeurs-29.fr\/Accueil\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/registre-tumeurs-29.fr\/Accueil\/wp-json\/wp\/v2\/comments?post=1315"}],"version-history":[{"count":27,"href":"https:\/\/registre-tumeurs-29.fr\/Accueil\/wp-json\/wp\/v2\/pages\/1315\/revisions"}],"predecessor-version":[{"id":3094,"href":"https:\/\/registre-tumeurs-29.fr\/Accueil\/wp-json\/wp\/v2\/pages\/1315\/revisions\/3094"}],"wp:attachment":[{"href":"https:\/\/registre-tumeurs-29.fr\/Accueil\/wp-json\/wp\/v2\/media?parent=1315"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}

{"id":1315,"date":"2019-02-20T16:48:35","date_gmt":"2019-02-20T15:48:35","guid":{"rendered":"http:\/\/registre-tumeurs-29.fr\/accueil\/?page_id=1315"},"modified":"2026-03-12T14:45:42","modified_gmt":"2026-03-12T13:45:42","slug":"travaux-et-resultats","status":"publish","type":"page","link":"https:\/\/registre-tumeurs-29.fr\/Accueil\/travaux-et-resultats\/","title":{"rendered":"Publications et communications"},"content":{"rendered":"\n\n\n\n \n \n Communications & Publications 2020\u20132025<\/title>\n <style>\n :root{\n --bg:#f7f9fc; --card:#ffffff; --text:#0b1324; --muted:#6b7280;\n --primary:#0ea5e9; --primary-600:#0284c7; --border:#e5e7eb;\n --shadow:0 10px 30px rgba(2,8,23,.08); --radius:18px;\n --ring:0 0 0 6px rgba(14,165,233,.10);\n }\n body{background:var(--bg); color:var(--text); font-family:system-ui,Segoe UI,Roboto,Helvetica,Arial,sans-serif; line-height:1.65; margin:0}\n a{color:var(--primary-600); text-decoration:none}\n a:hover{text-decoration:underline}\n .container{max-width:1280px;margin:0 auto;padding:22px 20px 96px}\n .hero{background:radial-gradient(1000px 500px at 10% -10%,rgba(14,165,233,.10),transparent),radial-gradient(800px 400px at 90% 0%,rgba(142,68,173,.06),transparent);border:1px solid var(--border);border-radius:28px;padding:30px;box-shadow:var(--shadow)}\n .hero h1{margin:0 0 8px;font-size:2.15rem;letter-spacing:-.02em}\n .quicknav{display:flex;flex-wrap:wrap;gap:10px;margin:16px 0 0}\n .quicknav a{color:#0b1324; font-weight:700; padding:10px 16px; border-radius:999px;border:1px solid var(--border); background:#fff; box-shadow:0 6px 18px rgba(2,8,23,.06);transition:transform .15s ease, box-shadow .2s ease}\n .quicknav a:hover{transform:translateY(-2px); box-shadow:0 14px 28px rgba(2,8,23,.10)}\n section{margin-top:26px}\n .card{background:var(--card);border:1px solid var(--border);border-radius:24px;padding:24px 24px 18px;box-shadow:var(--shadow)}\n .section-header{display:flex;align-items:center;gap:12px;margin:0 0 10px}\n .section-header h2{margin:0;font-size:1.35rem}\n .pill{display:inline-flex;align-items:center;justify-content:center;width:40px;height:40px;border-radius:14px;background:linear-gradient(180deg,rgba(14,165,233,.20),rgba(14,165,233,.08));border:1px solid rgba(14,165,233,.25)}\n .pill svg{width:20px;height:20px;stroke:var(--primary-600)}\n h3.muted{color:#0b1324;margin:12px 0 4px;font-size:1rem; font-weight:800; text-transform:uppercase; letter-spacing:.08em}\n ol{margin:4px 0 0;padding-left:0}\n li{list-style:none;margin:12px 0;padding:12px 14px;border:1px dashed var(--border);border-radius:14px;background:#fafcff}\n li:hover{background:#fff; border-color:#d7ddea; box-shadow:0 8px 20px rgba(2,8,23,.06)}\n .muted{color:var(--muted)}\n\n .two-cols {\n display: grid;\n grid-template-columns: 2fr 1fr;\n gap: 24px;\n margin-top: 30px;\n }\n .col-left {display:flex;flex-direction:column;gap:22px}\n .col-right {position:sticky;top:20px;height:fit-content}\n @media (max-width: 900px) {\n .two-cols {grid-template-columns:1fr}\n .col-right {position:relative;top:auto}\n }\n\n .info-grid{display:flex;flex-direction:column;gap:14px}\n .info{\n padding:14px 16px;\n border:1px solid var(--border);\n border-radius:16px;\n background:#fafcff;\n box-shadow:0 6px 18px rgba(2,8,23,.04);\n }\n .info strong{display:inline-block;margin-bottom:4px}\n .info.featured{\n background:linear-gradient(135deg,rgba(14,165,233,.08),rgba(142,68,173,.06));\n border-color:#cfe7f5;\n }\n .badge{\n display:inline-block;\n margin-left:8px;\n padding:3px 8px;\n border-radius:999px;\n font-size:.75rem;\n font-weight:800;\n color:#fff;\n background:linear-gradient(135deg,#0ea5e9,#8e44ad);\n vertical-align:middle;\n }\n <\/style>\n<\/head>\n<body>\n <div class=\"container\">\n <header class=\"hero\">\n <h1>Communications & Publications<\/h1>\n <nav class=\"quicknav\" aria-label=\"Navigation rapide\">\n <a href=\"#y2025\">2025<\/a>\n <a href=\"#y2024\">2024<\/a>\n <a href=\"#y2023\">2023<\/a>\n <a href=\"#y2022\">2022<\/a>\n <a href=\"#y2021\">2021<\/a>\n <a href=\"#y2020\">2020<\/a>\n <a href=\"#newsletters\">Newsletters<\/a>\n <\/nav>\n <\/header>\n\n <div class=\"two-cols\">\n <div class=\"col-left\">\n\n \n <section id=\"y2025\" class=\"card\">\n <div class=\"section-header\">\n <span class=\"pill\">\n <svg viewBox=\"0 0 24 24\" fill=\"none\" stroke-width=\"2\"><path d=\"M3 6h18M3 12h18M3 18h18\"><\/path><\/svg>\n <\/span>\n <h2>2025<\/h2>\n <\/div>\n\n <h3 class=\"muted\">Communications<\/h3>\n <ol>\n <li>Qu\u00e9n\u00e9herv\u00e9 L, Chagnon P, Morvan M, Arnachellum R, Cholet F, Bouzeloc S, Badic B, Doucet L, Nousbaum JB (Brest). Faut-il moins se m\u00e9fier des cancers colorectaux T1 d\u00e9velopp\u00e9s sur polypes p\u00e9dicul\u00e9s ? Une \u00e9tude r\u00e9trospective de population sur 12 ans. JFHOD; 20\u201323 mars <strong>2025<\/strong>; Paris. Poster.<\/li>\n <li>Motreff M, Morvan M, Arnachellum R, Cholet F, Bouzeloc S, Badic B, Doucet L, Nousbaum JB, Qu\u00e9n\u00e9herv\u00e9 L (Brest). Impact de la pr\u00e9sentation en r\u00e9union de concertation pluridisciplinaire des tumeurs superficielles digestives r\u00e9s\u00e9qu\u00e9es par endoscopie : \u00e9tude r\u00e9trospective. JFHOD; 20\u201323 mars <strong>2025<\/strong>; Paris. Communication orale.<\/li>\n <\/ol>\n\n <h3 class=\"muted\">Publications<\/h3>\n <ol>\n <li>Jooste V, Nousbaum JB, Alves A, Woronoff AS, Launoy G, Molini\u00e9 F, Desandes E, Delafosse P, Tretarre B, Mercier E, Lepage C, Ghiringhelli F, Bouvier AM; French Network of Cancer Registries (FRANCIM). Epidemiological Classification Changes and Incidence of Early-Onset Colorectal Cancer. JAMA Netw Open. <strong>2025<\/strong> Nov 3;8(11):e2541732. doi: 10.1001\/jamanetworkopen.2025.41732. PMID: 41191353; PMCID: PMC12590295.<\/li>\n <li>Botta L, Capocaccia R, Bernasconi A, Rossi S, Galceran J, Dal Maso L, Lepage C, Molini\u00e9 F, Bouvier AM, Marcos-Gragera R, Vener C, Guevara M, Murray D, Ragusa R, Gatta G, Jooste V; EUROCARE-6 WG. The impact of cancer survivors’ extra risk of noncancer mortality on net survival estimation. Am J Epidemiol. <strong>2025<\/strong> Nov 4;194(11):3316-3324. doi: 10.1093\/aje\/kwaf148. PMID: 40826891; PMCID: PMC12634115.<\/li>\n <li>Chaigneau T, Dejardin O, Nguyen TTN, Bouvier AM, Gardy J, Molinie F, Nousbaum JB, Tron L, Dupont B, Alves A, Launoy G, Bouvier V, Ollivier-Hourmand I; FRANCIM Group. The socioeconomic environment and access to care affect the survival of patients with hepatocellular carcinoma and intrahepatic cholangiocarcinoma. BMC Cancer. <strong>2025<\/strong> Nov 21. doi: 10.1186\/s12885-025-15174-w. Epub ahead of print. PMID: 41272602.<\/li>\n <li>Le Rochais M, Morvan M, Bouzeloc S, Nousbaum JB, Guillard M, Le Noac’h P, Garaud S, Uguen A. A tertiary lymphoid structures-based pathological score predicts survival and recurrence in colorectal cancer patients. <i>Immunobiology<\/i>. <strong>2025<\/strong>;230(3):152911. doi:10.1016\/j.imbio.2025.152911. PMID:40398138.<\/li>\n <li>Goebel G, Jooste V, Molinie F, Grosclaude P, Woronoff AS, Alves A, Bouvier V, Nousbaum JB, Plouvier S, Bengrine-Lefevre L, Rabel T, Bouvier AM; FRANCIM Network. Surgical patterns of care of pancreatic cancer: a French population-based study. <i>Eur J Surg Oncol<\/i>. <strong>2025<\/strong>;51(8):108748. doi:10.1016\/j.ejso.2024.108748. PMID:39419745.<\/li>\n <\/ol>\n <\/section>\n\n \n <section id=\"y2024\" class=\"card\">\n <div class=\"section-header\"><span class=\"pill\"><svg viewBox=\"0 0 24 24\" fill=\"none\" stroke-width=\"2\"><path d=\"M3 6h18M3 12h18M3 18h18\"><\/path><\/svg><\/span><h2>2024<\/h2><\/div>\n <h3 class=\"muted\">Communications<\/h3>\n <ol>\n <li>Chaigneau T, Dejardin O, Nguyen TTN, Bouvier AM, Gardy J, Molini\u00e9 F, Nousbaum JB, Tron L, Alves A, Launoy G, Bouvier V, Ollivier-Hourmand I. Influence de l\u2019acc\u00e8s aux soins et de l\u2019environnement socio-\u00e9conomique sur la survie des patients atteints de carcinome h\u00e9patocellulaire et de cholangiocarcinome intra-h\u00e9patique. JFHOD; 14\u201317 mars <strong>2024<\/strong>; Paris. Communication orale.<\/li>\n <li>Debuc Y, Morvan M, Can\u00e9vet M, Brousse-Potocki J, Kermarrec T, Bouzeloc S, Robaszkiewicz M, Reboux N, Qu\u00e9n\u00e9herv\u00e9 L, Nousbaum JB. Analyse et survie des patients atteints d\u2019un cancer colorectal selon le motif d\u2019exclusion du d\u00e9pistage organis\u00e9 (2016\u20132019). JFHOD; 14\u201317 mars <strong>2024<\/strong>; Paris. Poster.<\/li>\n <li>Kermarrec M, Robaszkiewicz M, Morvan M, Bideau K, Edeline J, Brousse-Potocki J, Grasset D, Lambert S, Metges JP, Langlois A, Pourchasse C, Desgrippes R. Cons\u00e9quence de la Covid-19 sur la prise en charge des patients atteints de cancer colorectal en Bretagne. JFHOD; 14\u201317 mars <strong>2024<\/strong>; Paris. Poster.<\/li>\n <\/ol>\n <h3 class=\"muted\">Publications<\/h3>\n <ol>\n <li>Gardy J, Wilson S, Guizard AV, Bouvier V, Launay L, Alves A, Bara S, Bouvier AM, Coureau G, Cowppli-Bony A, Dabakuyo Yonli S, Daubisse-Marliac L, Defossez G, Hammas K, Hure F, Jooste V, Lapotre-Ledoux B, Nousbaum JB, Plouvier S, Seigneurin A, Tretarre B, Vigneron N, Woronoff AS, Launoy G, Molinie F, Bryere J, Dejardin O. Access to primary care and mortality in excess for patients with cancer in France: results from 21 registries. <i>Cancer<\/i>. <strong>2024<\/strong>;130(23):4096\u20134108. doi:10.1002\/cncr.35519. PMID:39163260.<\/li>\n <li>Comoz B, Ollivier-Hourmand I, Bouvier AM, Nousbaum JB, Nguyen TTN, Launoy G, Bouvier V, Bryere J. Impact of socio-economic environment on incidence of primary liver cancer in France between 2006 and 2016. <i>Liver Int<\/i>. <strong>2024<\/strong>;44(2):446\u2013453. doi:10.1111\/liv.15784. PMID:38010978.<\/li>\n <li>Toudic HP, Morvan M, Reboux N, Chaussade S, Gronier O, Koch S, Bernardini D, Coron E, Robaszkiewicz M, Qu\u00e9n\u00e9herv\u00e9 L. Expansion of interventional endoscopy and day-case procedures: a nationwide longitudinal study of gastrointestinal endoscopy in France. <i>Clin Res Hepatol Gastroenterol<\/i>. <strong>2024<\/strong>;49(1):102505. doi:10.1016\/j.clinre.2024.102505. PMID:39608706.<\/li>\n <li>Sant M, Vener C, Lillini R, Rossi S, Bonfarnuzzo S, Marcos-Gragera R, Maynadi\u00e9 M, Innos K, Paapsi K, Visser O, Bernasconi A, Demuru E, Di Benedetto C, Mousavi SM, Blum M, Went P, Serraino D, Bennett D, S\u00e1nchez MJ, De Angelis R; EUROCARE-6 Working Group. Long-term survival for lymphoid neoplasms and national health expenditure (EUROCARE-6). <i>Lancet Oncol<\/i>. <strong>2024<\/strong>;25(6):731\u2013743. doi:10.1016\/S1470-2045(24)00141-4. PMID:38703784.<\/li>\n <li>Botta L, Capocaccia R, Bernasconi A, Rossi S, Galceran J, Maso DL, Lepage C, Molini\u00e9 F, Bouvier AM, Marcos-Gragera R, Vener C, Guevara M, Murray D, Ragusa R, Gatta G, Jooste V; EUROCARE-6 Working Group. Estimating cure and risk of death from other causes: EUROCARE-6 data. <i>Eur J Cancer<\/i>. <strong>2024<\/strong>;208:114187. doi:10.1016\/j.ejca.2024.114187. PMID:39013266.<\/li>\n <li>Bouvier AM, Jooste V, Lillini R, Marcos-Gragera R, Katalinic A, Giorgi Rossi P, Launoy G, Bouvier V, Guevara M, Ardanaz E, Rapiti Aylward E, Innos K, Barranco MR, Sant M; European High Resolution Working Group on Colorectum. Differences in survival and recurrence of colorectal cancer by stage across European registries. <i>Int J Cancer<\/i>. <strong>2024<\/strong>;155(5):807\u2013815. doi:10.1002\/ijc.34944. PMID:38577898.<\/li>\n <li>Jooste V, Grosclaude P, Defossez G, Daubisse L, Woronoff AS, Bouvier V, Chirpaz E, Tretarre B, Lapotre B, Plouvier S, Launoy G, Bonneault M, Molini\u00e9 F, Bouvier AM; FRANCIM Network. Net survival in colon and rectal cancer by stage according to neoadjuvant treatment: a French population-based study. <i>Dig Liver Dis<\/i>. <strong>2024<\/strong>;56(6):1064\u20131070. doi:10.1016\/j.dld.2023.10.012. PMID:37926634.<\/li>\n <\/ol>\n <\/section>\n\n \n <section id=\"y2023\" class=\"card\">\n <div class=\"section-header\"><span class=\"pill\"><svg viewBox=\"0 0 24 24\" fill=\"none\" stroke-width=\"2\"><path d=\"M3 6h18M3 12h18M3 18h18\"><\/path><\/svg><\/span><h2>2023<\/h2><\/div>\n <h3 class=\"muted\">Communications<\/h3>\n <ol>\n <li>Comoz B, Bryere J, Bouvier AM, Nousbaum JB, Launoy G, Bouvier V, Ollivier-Hourmand I. Disparit\u00e9s socio-\u00e9conomiques et incidence du cancer primitif du foie (2006\u20132016). JFHOD; 16\u201319 mars <strong>2023<\/strong>; Paris. Communication orale.<\/li>\n <li>Nguyen TTN, Dejardin O, Bouvier AM, Nousbaum JB, Molini\u00e9 F, Gardy J, Launoy G, Bouvier V, Ollivier-Hourmand I. In\u00e9galit\u00e9s socio-\u00e9conomiques et survie des cancers primitifs du foie. JFHOD; 16\u201319 mars <strong>2023<\/strong>; Paris. Communication orale.<\/li>\n <li>Corbel T, Morvan M, Bouzeloc S, Kermarrec T, Nousbaum JB, Le Reste JY, Reboux N, Qu\u00e9n\u00e9herv\u00e9 L, Robaszkiewicz M. Distribution des kits par pharmaciens et performance du d\u00e9pistage organis\u00e9 du cancer colorectal : \u00e9tude de population. JFHOD; 16\u201319 mars <strong>2023<\/strong>; Paris. Poster.<\/li>\n <\/ol>\n <h3 class=\"muted\">Publications<\/h3>\n <ol>\n <li>Badic B, Morvan M, Qu\u00e9n\u00e9herv\u00e9 L, Bouzeloc S, Kermarrec T, Nousbaum JB, Reboux N. Real world data for pancreatic adenocarcinoma from a population-based study in France. <i>Cancers (Basel)<\/i>. <strong>2023<\/strong>;15(2):525. doi:10.3390\/cancers15020525. PMID:36672474.<\/li>\n <li>Thobie A, Bouvier AM, Bouvier V, Jooste V, Quen\u00e9herv\u00e9 L, Nousbaum JB, Alves A, Dejardin O. Survival variability across hospitals after resection for pancreatic adenocarcinoma: a multilevel survival analysis. <i>Eur J Surg Oncol<\/i>. <strong>2023<\/strong>;49(8):1450\u20131456. doi:10.1016\/j.ejso.2023.03.228. PMID:37055280.<\/li>\n <li>Can\u00e9vet M, Pruvost-Couvreur M, Morvan M, Badic B, Brousse-Potocki J, Kermarrec T, Bouzeloc S, Nousbaum JB, Robaszkiewicz M, Reboux N, Qu\u00e9n\u00e9herv\u00e9 L. Sensitivity of fecal immunochemical test and risk factors for interval colorectal cancer in a French population. <i>Clin Res Hepatol Gastroenterol<\/i>. <strong>2023<\/strong>;47(3):102093. doi:10.1016\/j.clinre.2023.102093. PMID:36764389.<\/li>\n <li>Matz M, Valkov M, \u0160ekerija M, Luttman S, Caldarella A, Coleman MP, Allemani C; CONCORD Working Group. Worldwide trends in esophageal cancer survival, by sub-site, morphology, and sex: an analysis of 696,974 adults diagnosed in 60 countries during 2000\u20132014(CONCORD-3). <i>Cancer Commun (Lond)<\/i>. <strong>2023<\/strong>;43(9):963\u2013980. doi:10.1002\/cac2.12457. PMID:37488785.<\/li>\n <li>Nik\u0161i\u0107 M, Minicozzi P, Weir HK, Zimmerman H, Schymura MJ, Rees JR, Coleman MP, Allemani C; US CONCORD Working Group. Pancreatic cancer survival trends in the US from 2001 to 2014: a CONCORD-3 study. <i>Cancer Commun (Lond)<\/i>. <strong>2023<\/strong>;43(1):87\u201399. doi:10.1002\/cac2.12375. PMID:36353792.<\/li>\n <li>Tron L, Remontet L, Fauvernier M, Rachet B, Belot A, Launay L, Merville O, Molini\u00e9 F, Dejardin O, Francim Group, Launoy G. Is the social gradient in net survival observed in France the result of inequalities in cancer-specific mortality or inequalities in general mortality? <i>Cancers (Basel)<\/i>. <strong>2023<\/strong>;15(3):659. doi:10.3390\/cancers15030659. PMID:36765616.<\/li>\n <li>Demuru E, Rossi S, Ventura L, Dal Maso L, Guzzinati S, Katalinic A, Lamy S, Jooste V, Di Benedetto C, De Angelis R; EUROCARE-6 Working Group. Estimating complete cancer prevalence in Europe: validity of alternative vs standard completeness indexes. <i>Front Oncol<\/i>. <strong>2023<\/strong>;13:1114701. doi:10.3389\/fonc.2023.1114701. PMID:37168378.<\/li>\n <\/ol>\n <\/section>\n\n \n <section id=\"y2022\" class=\"card\">\n <div class=\"section-header\"><span class=\"pill\"><svg viewBox=\"0 0 24 24\" fill=\"none\" stroke-width=\"2\"><path d=\"M3 6h18M3 12h18M3 18h18\"><\/path><\/svg><\/span><h2>2022<\/h2><\/div>\n <h3 class=\"muted\">Communications<\/h3>\n <ol>\n <li>Canevet M, Pruvost-Couvreur M, Badic B, Brousse-Potocki J, Le Reun S, Kermarrec T, Bouzeloc S, Nousbaum JB, Robaszkiewicz M, Reboux N, Qu\u00e9n\u00e9herv\u00e9 L. Sensitivity of faecal immunochemical test for colorectal cancer screening and risk factors for interval cancer: a French population-based study. ESGE Days <strong>2022<\/strong>; Prague. Communication orale.<\/li>\n <li>Gieu M, Pruvost-Couvreur M, Kermarrec T, Bouzeloc S, Reboux N, Poureau PG, Metges JP, Robaszkiewicz M, Nousbaum JB, Qu\u00e9n\u00e9herv\u00e9 L. Facteurs associ\u00e9s \u00e0 la non-pr\u00e9sentation en RCP des patients atteints d\u2019un cancer de l\u2019\u0153sophage, de la JOG et de l\u2019estomac. JFHOD <strong>2022<\/strong>; Paris. Poster.<\/li>\n <li>Canevet M, Pruvost-Couvreur M, Kermarrec T, Bouzeloc S, Brousse-Potocki J, Le Reun S, Badic B, Nousbaum JB, Robaszkiewicz M, Reboux N, Qu\u00e9n\u00e9herv\u00e9 L. Sensibilit\u00e9 du test immunologique f\u00e9cal pour le d\u00e9pistage du CCR et risque de cancer d\u2019intervalle. JFHOD <strong>2022<\/strong>; Paris. Poster.<\/li>\n <\/ol>\n <h3 class=\"muted\">Publications<\/h3>\n <ol>\n <li>Reboux N, Jooste V, Goungounga J, Robaszkiewicz M, Nousbaum JB, Bouvier AM. Incidence and survival in synchronous and metachronous liver metastases from colorectal cancer. <i>JAMA Netw Open<\/i>. <strong>2022<\/strong>;5(10):e2236666.<\/li>\n <li>Badic B, Bouvier AM, Bouvier V, Morvan M, Jooste V, Alves A, Nousbaum JB, Reboux N. Predictors of survival in elderly patients with metastatic colon cancer: a population-based cohort study. <i>Cancers (Basel)<\/i>. <strong>2022<\/strong>;14(21):5208.<\/li>\n <li>Mulliri A, Gardy J, Cariou M, Launoy G, Robaszkiewicz M, Alves A, Bouvier V, Dejardin O. Care management and survival of patients diagnosed with synchronous metastatic colorectal cancer: a population-based study. <i>Cancers (Basel)<\/i>. <strong>2022<\/strong>;14(7):1777.<\/li>\n <li>Thomas F, Bouvier AM, Cariou M, Bouvier V, Jooste V, Pouchucq C, Gardy J, Qu\u00e9n\u00e9herv\u00e9 L, Launoy G, Alves A, Eid Y, Dejardin O. Influence of non-clinical factors on restorative rectal cancer surgery. <i>Dig Liver Dis<\/i>. <strong>2022<\/strong>;54(2):258\u2013267.<\/li>\n <li>Reboux N, Cadieu E, Pruvost-Couvreur M, Cariou M, Kermarrec M, Kermarrec T, Bouzeloc S, Nousbaum JB, Robaszkiewicz M, Qu\u00e9n\u00e9herv\u00e9 L. Factors associated with non-presentation in a multidisciplinary team meeting for colon cancer. <i>Clin Res Hepatol Gastroenterol<\/i>. <strong>2022<\/strong>;46(8):101950.<\/li>\n <li>Aujoulat P, Le Goff D, Dany A, Robaszkiewicz M, Nousbaum JB, Derriennic J, Cariou M, Guillou M, Le Reste JY. Improvement of participation rate in CRC screening by training GPs in motivational interviewing (AmDepCCR). <i>Trials<\/i>. <strong>2022<\/strong>;23(1):144.<\/li>\n <li>Cardoso R, Guo F, Heisser T, De Schutter H, Van Damme N, Nilbert MC, Christensen J, et al. Overall and stage-specific survival of patients with screen-detected colorectal cancer in Europe. <i>Lancet Reg Health Eur<\/i>. <strong>2022<\/strong>;21:100458.<\/li>\n <li>Ssenyonga N, Stiller C, Nakata K, Shalkow J, Redmond S, Bulliard JL, et al; CONCORD Working Group. Worldwide trends in survival for leukaemia in children, adolescents, and young adults. <i>Lancet Child Adolesc Health<\/i>. <strong>2022<\/strong>;6(6):409\u2013431.<\/li>\n <\/ol>\n <\/section>\n\n \n <section id=\"y2021\" class=\"card\">\n <div class=\"section-header\"><span class=\"pill\"><svg viewBox=\"0 0 24 24\" fill=\"none\" stroke-width=\"2\"><path d=\"M3 6h18M3 12h18M3 18h18\"><\/path><\/svg><\/span><h2>2021<\/h2><\/div>\n <h3 class=\"muted\">Communications<\/h3>\n <ol>\n <li>Pruvost-Couvreur M, Kermarrec M (OncoBretagne). \u00c9tude de l\u2019exhaustivit\u00e9 de la pr\u00e9sentation en RCP pour le cancer du c\u00f4lon : \u00e9tude collaborative. Congr\u00e8s National des R\u00e9seaux de Canc\u00e9rologie; sept. <strong>2021<\/strong>. Communication orale.<\/li>\n <li>Garcia GA, Cariou M, Reboux N, Kermarrec T, Bouzeloc S, Robaszkiewicz M, Qu\u00e9n\u00e9herv\u00e9 L, Nousbaum JB. Survie des patients atteints de cholangiocarcinome intra-h\u00e9patique (2005\u20132017). JFHOD; 18\u201321 mars <strong>2021<\/strong>; Paris. Communication orale.<\/li>\n <li>Bouvier AM, Uhry Z, Bouvier V, Cariou M, Robaszkiewicz M, Remontet L, Coureau G, Tretarre B. Long term colorectal cancer survival in France : population-based study. 45e GRELL; 12\u201314 mai <strong>2021<\/strong>; Luxembourg. Communication orale.<\/li>\n <li>Gaye E, Cariou M, Bore P, Poureau PG, Bouzeloc S, Doucet L, Jestin-Letallec V, Bideau K, Thereaux J, Robaszkiewicz M, Metges JP. Survie des carcinomes \u00e9pidermo\u00efdes de l\u2019\u0153sophage et de la JOG m\u00e9tastatiques (2009\u20132018) \u2013 ESPErE. JFHOD; mars <strong>2021<\/strong>. Poster.<\/li>\n <li>Bore P, Cariou M, Gaye E, Bouzeloc S, Nousbaum JB, Robaszkiewicz M, Jestin-Letallec V, Bideau K, Thereaux J, Poureau PG, Metges JP. HEROIC \u2013 Attitudes th\u00e9rapeutiques et tol\u00e9rance des ad\u00e9nocarcinomes \u0153sogastriques HER2+. JFHOD; mars <strong>2021<\/strong>. Poster.<\/li>\n <li>Thomas Q, Cariou M, Qu\u00e9n\u00e9herv\u00e9 L, Kermarrec T, Kermarrec M, Bouzeloc S, Robaszkiewicz M, Nousbaum JB, Reboux N. Exhaustivit\u00e9 de la pr\u00e9sentation en RCP des carcinomes h\u00e9patocellulaires (2014\u20132016). JFHOD; mars <strong>2021<\/strong>. Poster.<\/li>\n <li>Cadieu E, Cariou M, Kermarrec M, Bouzeloc S, Reboux N, Nousbaum JB, Robaszkiewicz M, Qu\u00e9n\u00e9herv\u00e9 L. Exhaustivit\u00e9 de la pr\u00e9sentation en RCP des cancers du c\u00f4lon (2014\u20132016). JFHOD; mars <strong>2021<\/strong>. Poster.<\/li>\n <\/ol>\n <h3 class=\"muted\">Publications<\/h3>\n <ol>\n <li>Badic B, Oguer M, Cariou M, Kermarrec T, Bouzeloc S, Nousbaum JB, Robaszkiewicz M, Qu\u00e9n\u00e9herv\u00e9 L. Ostomy prevalence and survival in elderly patients with stage III and IV rectal cancer. <i>Geriatr Gerontol Int<\/i>. <strong>2021<\/strong>;21(8):670\u2013675.<\/li>\n <li>Badic B, Oguer M, Cariou M, Kermarrec T, Bouzeloc S, Nousbaum JB, Robaszkiewicz M, Qu\u00e9n\u00e9herv\u00e9 L. Prognostic factors for stage III colon cancer in patients \u226580 years. <i>Int J Colorectal Dis<\/i>. <strong>2021<\/strong>;36(4):811\u2013819.<\/li>\n <li>Castillon M, Kammerer-Jacquet SF, Cariou M, Costa S, Conq G, Samaison L, Douet-Guilbert N, Marcorelles P, Doucet L, Uguen A. FISH must be preferred to pan-TRK IHC for NTRK3-rearranged GIST. <i>Appl Immunohistochem Mol Morphol<\/i>. <strong>2021<\/strong>;29(8):626\u2013634.<\/li>\n <li>Bocciarelli C, Caumont C, Samaison L, Cariou M, Aline-Fardin A, Doucet L, Roudi\u00e9 J, Terris B, Merlio JP, Marcorelles P, Cappellen D, Uguen A. MSI-high RAS-BRAF wt colorectal adenocarcinomas with MLH1 loss harbor frequent targetable fusions. <i>Hum Pathol<\/i>. <strong>2021<\/strong>;114:99\u2013109.<\/li>\n <li>Cardoso R, Guo F, Heisser T, Hackl M, et al. CRC incidence, mortality, and stage distribution in Europe in the screening era. <i>Lancet Oncol<\/i>. <strong>2021<\/strong>;22(7):1002\u20131013.<\/li>\n <li>Defossez G, Uhry Z, Delafosse P, Dantony E, et al; FRANCIM. Cancer incidence and mortality trends in France (1990\u20132018). <i>BMC Cancer<\/i>. <strong>2021<\/strong>;21:726.<\/li>\n <li>Bouvier AM, Jooste V, Sanchez-Perez MJ, et al; Working Group on Colorectum. Management and survival of metastatic colorectal cancer in Europe. <i>Dig Liver Dis<\/i>. <strong>2021<\/strong>;53(5):639\u2013645.<\/li>\n <li>Girardi F, Rous B, Stiller CA, et al; CONCORD Working Group. Histology of brain tumors (2000\u20132014): a global population-based study. <i>Neuro Oncol<\/i>. <strong>2021<\/strong>;23(10):1765\u20131776.<\/li>\n <li>Tron L, Fauvernier M, Bouvier AM, Robaszkiewicz M, Bouvier V, Cariou M, Jooste V, Dejardin O, Remontet L, Alves A, FRANCIM Group, Molini\u00e9 F, Launoy G. Socioeconomic environment and survival in digestive cancers. <i>Cancers (Basel)<\/i>. <strong>2021<\/strong>;13(20):5156.<\/li>\n <li>Bouvier V, Cariou M, Bouvier AM, Nousbaum JB, Lecoffre C, de Brauer C, et al. Survie des personnes atteintes de cancer en France m\u00e9tropolitaine 1989\u20132018 \u2014 V\u00e9sicule et voies biliaires. INCa; <strong>2021<\/strong>.<\/li>\n <\/ol>\n <\/section>\n\n \n <section id=\"y2020\" class=\"card\">\n <div class=\"section-header\"><span class=\"pill\"><svg viewBox=\"0 0 24 24\" fill=\"none\" stroke-width=\"2\"><path d=\"M3 6h18M3 12h18M3 18h18\"><\/path><\/svg><\/span><h2>2020<\/h2><\/div>\n <h3 class=\"muted\">Communications<\/h3>\n <ol>\n <li>Drouet d’Aubigny A, Cariou M, Cholet F, Jezequel J, Arnachellum R, Risson JR, H\u00e9bert T, Nonent M, Robaszkiewicz M, Nousbaum JB. \u00c9laboration d’un score pronostique chez les malades ayant un obstacle biliaire n\u00e9oplasique. JFHOD; 26\u201329 mars <strong>2020<\/strong>; Paris. Communication orale.<\/li>\n <li>Cardoso R, Hackl M, Ihle P, De Schutter H, Van Damme N, Valerianova Z, et al. Trends in colorectal cancer incidence and stage distribution in Europe in the screening era. UEG Week; 10\u201314 oct. <strong>2020<\/strong>; Amsterdam. Communication orale.<\/li>\n <li>d’Aubigny A, Cariou M, Cholet F, Jezequel J, Arnachellum R, Risson JR, H\u00e9bert T, Nonent M, Robaszkiewicz M, Nousbaum JB. Elaboration of a prognostic score in patients with malignant biliary obstruction. ESGE Days; 23\u201325 avr. 2020; virtuel. Poster. <i>Endoscopy<\/i>. <strong>2020<\/strong>;52(S01):204. doi:10.1055\/s-0040-1704635.<\/li>\n <\/ol>\n <h3 class=\"muted\">Publications<\/h3>\n <ol>\n <li>Uhry Z, Chatignoux E, Dantony E, Colonna M, Roche L, Fauvernier M, Defossez G, Le Guyader-Peyrou S, Monnereau A, Grosclaude P, Bossard N, Remontet L; FRANCIM. Multidimensional penalized splines for incidence and mortality-trend analyses and validation of national cancer-incidence estimates. <i>Int J Epidemiol<\/i>. <strong>2020<\/strong>;49(6):1762\u20131770.<\/li>\n <li>Bouvier AM, Robaszkiewicz M, Jooste V, Cariou M, Drouillard A, Bouvier V, Nousbaum JB; FRANCIM. Trends in incidence of small bowel cancer according to histology: a population-based study. <i>J Gastroenterol<\/i>. <strong>2020<\/strong>;55(2):181\u2013188.<\/li>\n <li>Bourhis A, De Luca C, Cariou M, Vigliar E, Barel F, Conticelli F, Marcorelles P, Nousbaum JB, Robaszkiewicz M, Samaison L, Badic B, Doucet L, Troncone G, Uguen A. Evaluation of KRAS, NRAS and BRAF mutational status and microsatellite instability in early colorectal carcinomas invading the submucosa (pT1): towards an in-house molecular prognostication for pathologists? <i>J Clin Pathol<\/i>. <strong>2020<\/strong>;73(11):741\u2013747.<\/li>\n <li>Cariou M, El Fettouhi A, Kermarrec T, Bommelaere F, Foll Y, Nousbaum JB, Robaszkiewicz M, Qu\u00e9n\u00e9herv\u00e9 L. Comparative evaluation of two colorectal cancer screening campaigns using different faecal occult blood tests in a French area. <i>Cancer Epidemiol<\/i>. <strong>2020<\/strong>;69:101839.<\/li>\n <li>\u00ab Survie des personnes atteintes de cancer en France m\u00e9tropolitaine (1989\u20132018) \u00bb \u2014 sites digestifs (\u0153sophage \u2014 ad\u00e9nocarcinomes, \u0153sophage \u2014 \u00e9pidermo\u00efdes et synth\u00e8se, estomac, c\u00f4lon, rectum, c\u00f4lon & rectum, anus, foie, pancr\u00e9as). Boulogne-Billancourt : INCa; <strong>2020<\/strong>.<\/li>\n <\/ol>\n <\/section>\n\n <\/div>\n\n \n <div class=\"col-right\">\n <section id=\"newsletters\" class=\"card\">\n <div class=\"section-header\">\n <span class=\"pill\">\n <svg viewBox=\"0 0 24 24\" fill=\"none\" stroke-width=\"2\">\n <path d=\"M4 4h16v16H4z\"><\/path>\n <path d=\"M4 9h16\"><\/path>\n <path d=\"M9 15h1\"><\/path>\n <\/svg>\n <\/span>\n <h2>Newsletters du Registre<\/h2>\n <\/div>\n\n <div class=\"info-grid\">\n <div class=\"info featured\">\n <strong>Newsletter RTDF 2026<\/strong>\n <span class=\"badge\">Nouveau<\/span><br \/>\n <a href=\"https:\/\/registre-tumeurs-29.fr\/wp-content\/uploads\/2026\/03\/2026_Newsletter_Registre_Finistere.pdf\" target=\"_blank\" rel=\"noopener\">T\u00e9l\u00e9charger (PDF)<\/a>\n <\/div>\n\n <div class=\"info\">\n <strong>Newsletter RTDF 2025<\/strong><br \/>\n <a href=\"https:\/\/registre-tumeurs-29.fr\/wp-content\/uploads\/2025\/09\/Newsletter_RTDF_2025.pdf\" target=\"_blank\" rel=\"noopener\">T\u00e9l\u00e9charger (PDF)<\/a>\n <\/div>\n\n <div class=\"info\">\n <strong>Newsletter RTDF 2024<\/strong><br \/>\n <a href=\"https:\/\/registre-tumeurs-29.fr\/wp-content\/uploads\/2024\/06\/Newsletter-Registre-du-Finistere_2024.pdf\" target=\"_blank\" rel=\"noopener\">T\u00e9l\u00e9charger (PDF)<\/a>\n <\/div>\n\n <div class=\"info\">\n <strong>Lettre d\u2019information RTDF 2021<\/strong><br \/>\n <a href=\"https:\/\/registre-tumeurs-29.fr\/wp-content\/uploads\/2021\/11\/Lettre-information-RTDF-2021.pdf\" target=\"_blank\" rel=\"noopener\">T\u00e9l\u00e9charger (PDF)<\/a>\n <\/div>\n <\/div>\n <\/section>\n <\/div>\n\n <\/div>\n <\/div>\n<\/body>\n<\/html>\n\n\n\n\n<p><\/p>","protected":false},"excerpt":{"rendered":"<p>Communications & Publications 2020\u20132025 Communications & Publications 2025 2024 2023 2022 2021 2020 Newsletters 2025 Communications Qu\u00e9n\u00e9herv\u00e9 L, Chagnon P, Morvan M, Arnachellum R, Cholet F, Bouzeloc S, Badic B, Doucet L, Nousbaum JB (Brest). Faut-il moins se m\u00e9fier des cancers colorectaux T1 d\u00e9velopp\u00e9s sur polypes p\u00e9dicul\u00e9s ? Une \u00e9tude r\u00e9trospective de population sur 12 […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":15,"comment_status":"closed","ping_status":"closed","template":"","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":[],"rop_publish_now_history":[],"rop_publish_now_status":"pending","_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":""},"class_list":["post-1315","page","type-page","status-publish","hentry"],"yoast_head":"\n<title>Publications et communications - REGISTRE DES TUMEURS DIGESTIVES DU FINISTERE<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/registre-tumeurs-29.fr\/Accueil\/travaux-et-resultats\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Publications et communications - REGISTRE DES TUMEURS DIGESTIVES DU FINISTERE\" \/>\n<meta property=\"og:description\" content=\"Communications & Publications 2020\u20132025 Communications & Publications 2025 2024 2023 2022 2021 2020 Newsletters 2025 Communications Qu\u00e9n\u00e9herv\u00e9 L, Chagnon P, Morvan M, Arnachellum R, Cholet F, Bouzeloc S, Badic B, Doucet L, Nousbaum JB (Brest). Faut-il moins se m\u00e9fier des cancers colorectaux T1 d\u00e9velopp\u00e9s sur polypes p\u00e9dicul\u00e9s ? Une \u00e9tude r\u00e9trospective de population sur 12 […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/registre-tumeurs-29.fr\/Accueil\/travaux-et-resultats\/\" \/>\n<meta property=\"og:site_name\" content=\"REGISTRE DES TUMEURS DIGESTIVES DU FINISTERE\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-12T13:45:42+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"14 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/registre-tumeurs-29.fr\/Accueil\/travaux-et-resultats\/\",\"url\":\"https:\/\/registre-tumeurs-29.fr\/Accueil\/travaux-et-resultats\/\",\"name\":\"Publications et communications - REGISTRE DES TUMEURS DIGESTIVES DU FINISTERE\",\"isPartOf\":{\"@id\":\"https:\/\/registre-tumeurs-29.fr\/Accueil\/#website\"},\"datePublished\":\"2019-02-20T15:48:35+00:00\",\"dateModified\":\"2026-03-12T13:45:42+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/registre-tumeurs-29.fr\/Accueil\/travaux-et-resultats\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/registre-tumeurs-29.fr\/Accueil\/travaux-et-resultats\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/registre-tumeurs-29.fr\/Accueil\/travaux-et-resultats\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/registre-tumeurs-29.fr\/Accueil\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Publications et communications\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/registre-tumeurs-29.fr\/Accueil\/#website\",\"url\":\"https:\/\/registre-tumeurs-29.fr\/Accueil\/\",\"name\":\"REGISTRE DES TUMEURS DIGESTIVES DU FINISTERE\",\"description\":\"Equipe d'Accueil EA 7479 SPURBO - Soins Primaires, Sant\u00e9 Publique et Registre des cancers de Bretagne Occidentale\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/registre-tumeurs-29.fr\/Accueil\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"}]}<\/script>\n","yoast_head_json":{"title":"Publications et communications - REGISTRE DES TUMEURS DIGESTIVES DU FINISTERE","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/registre-tumeurs-29.fr\/Accueil\/travaux-et-resultats\/","og_locale":"fr_FR","og_type":"article","og_title":"Publications et communications - REGISTRE DES TUMEURS DIGESTIVES DU FINISTERE","og_description":"Communications & Publications 2020\u20132025 Communications & Publications 2025 2024 2023 2022 2021 2020 Newsletters 2025 Communications Qu\u00e9n\u00e9herv\u00e9 L, Chagnon P, Morvan M, Arnachellum R, Cholet F, Bouzeloc S, Badic B, Doucet L, Nousbaum JB (Brest). Faut-il moins se m\u00e9fier des cancers colorectaux T1 d\u00e9velopp\u00e9s sur polypes p\u00e9dicul\u00e9s ? Une \u00e9tude r\u00e9trospective de population sur 12 […]","og_url":"https:\/\/registre-tumeurs-29.fr\/Accueil\/travaux-et-resultats\/","og_site_name":"REGISTRE DES TUMEURS DIGESTIVES DU FINISTERE","article_modified_time":"2026-03-12T13:45:42+00:00","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"14 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/registre-tumeurs-29.fr\/Accueil\/travaux-et-resultats\/","url":"https:\/\/registre-tumeurs-29.fr\/Accueil\/travaux-et-resultats\/","name":"Publications et communications - REGISTRE DES TUMEURS DIGESTIVES DU FINISTERE","isPartOf":{"@id":"https:\/\/registre-tumeurs-29.fr\/Accueil\/#website"},"datePublished":"2019-02-20T15:48:35+00:00","dateModified":"2026-03-12T13:45:42+00:00","breadcrumb":{"@id":"https:\/\/registre-tumeurs-29.fr\/Accueil\/travaux-et-resultats\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/registre-tumeurs-29.fr\/Accueil\/travaux-et-resultats\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/registre-tumeurs-29.fr\/Accueil\/travaux-et-resultats\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/registre-tumeurs-29.fr\/Accueil\/"},{"@type":"ListItem","position":2,"name":"Publications et communications"}]},{"@type":"WebSite","@id":"https:\/\/registre-tumeurs-29.fr\/Accueil\/#website","url":"https:\/\/registre-tumeurs-29.fr\/Accueil\/","name":"REGISTRE DES TUMEURS DIGESTIVES DU FINISTERE","description":"Equipe d'Accueil EA 7479 SPURBO - Soins Primaires, Sant\u00e9 Publique et Registre des cancers de Bretagne Occidentale","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/registre-tumeurs-29.fr\/Accueil\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"}]}},"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/registre-tumeurs-29.fr\/Accueil\/wp-json\/wp\/v2\/pages\/1315","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/registre-tumeurs-29.fr\/Accueil\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/registre-tumeurs-29.fr\/Accueil\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/registre-tumeurs-29.fr\/Accueil\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/registre-tumeurs-29.fr\/Accueil\/wp-json\/wp\/v2\/comments?post=1315"}],"version-history":[{"count":27,"href":"https:\/\/registre-tumeurs-29.fr\/Accueil\/wp-json\/wp\/v2\/pages\/1315\/revisions"}],"predecessor-version":[{"id":3094,"href":"https:\/\/registre-tumeurs-29.fr\/Accueil\/wp-json\/wp\/v2\/pages\/1315\/revisions\/3094"}],"wp:attachment":[{"href":"https:\/\/registre-tumeurs-29.fr\/Accueil\/wp-json\/wp\/v2\/media?parent=1315"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}